-
D-Luciferin Workflows for BLI and ATP Assays
2026-09-22
D-Luciferin enables sensitive firefly luciferase readouts across live-cell imaging, intracellular ATP quantification, and longitudinal tumor studies. This practical guide connects substrate handling with reporter design, glioblastoma delivery research, and troubleshooting strategies that improve assay confidence.
-
Angiotensin III: From RAAS Signal to Translational Tool
2026-09-22
Angiotensin III is more than a downstream RAAS metabolite: it is a mechanistically useful probe of aldosterone signaling, pressor biology, AT1 and AT2 receptor pharmacology, and emerging peptide–viral receptor interactions. This article translates its biology into practical experimental strategy while defining the evidence boundaries for cardiovascular, neuroendocrine, and antiviral research.
-
SMYD2 Inhibition in Cisplatin-Induced Renal Fibrosis
2026-09-21
The reference study identifies SMYD2 as a pharmacologically tractable regulator of cisplatin-induced renal fibrosis and inflammation. Using AZ505 and LLY507 in animal and tubular epithelial-cell models, the authors connect SMYD2 inhibition with reduced epithelial-to-mesenchymal transition, inflammatory signaling, and Smad3/STAT3 activity, while highlighting the need for genetic and clinical validation.
-
PFHxS Disrupts Lipid Homeostasis via PPARα
2026-09-21
The reference study shows that environmentally relevant PFHxS exposure disrupts lipid homeostasis in zebrafish larvae and identifies PPARα activation as a plausible molecular initiating event. By integrating lipidomics, transcriptomics, molecular simulation, and antagonist coexposure, it connects altered lipid classes with specific signaling and metabolic pathways.
-
PTGER4–HDAC Signaling in Rectal Epithelium
2026-09-20
Anbazhagan et al. define a stromal–epithelial signaling mechanism in which mesenchymal stromal cell-derived PGE2 activates PTGER4 and alters class IIa HDAC phosphorylation in rectal organoids. This pathway increases SPINK4 mRNA and extracellular SPINK4, providing a mechanistic framework for epithelial repair and inflammation-related regulation.
-
Angiotensin II and the NAD+–Aneurysm Axis
2026-09-19
Angiotensin II is more than a vasopressor stimulus: it is a defined perturbation for connecting GPCR signaling, oxidative stress, vascular smooth muscle behavior, and extracellular-matrix metabolism. This translational framework uses recent evidence on mitochondrial NAD+ deficiency and collagen III turnover to guide more informative aneurysm and remodeling studies.
-
Upd2 Directs Tracheal Stem Cell Migration in Drosophila
2026-09-18
The reference preprint identifies a fat body-to-trachea signaling axis in which the cytokine Upd2 activates JAK/STAT signaling to preserve the anterior-to-posterior migration of Drosophila tracheal progenitors. Its findings connect inter-organ cytokine transport, planar cell polarity gene activity, and asymmetric Fat localization, providing a mechanistic framework for disciplined stem cell movement.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody
2026-09-18
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody, SKU K1209, provides fluorescent detection of rabbit IgG primary antibodies in immunofluorescence, immunocytochemistry, immunohistochemistry, and flow cytometry workflows. It should be used for research applications after assay-specific titration and controls, not for diagnostic, therapeutic, or unvalidated live-cell applications.
-
D-Luciferin Workflows for Metastasis Research
2026-09-17
D-Luciferin enables sensitive firefly luciferase readouts across live-cell imaging, intracellular ATP quantification, and longitudinal tumor burden assessment. This practical guide connects optimized substrate handling with the FGF19–ELF4–FGFR4/SRC metastasis model described in a colorectal cancer study.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody Guide
2026-09-17
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit IgG primary antibodies in immunofluorescence, immunohistochemistry, immunocytochemistry, and flow cytometry workflows. It is intended for research use only and should not be used for diagnostic, medical, or unvalidated live-cell applications.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody Workflow
2026-09-16
Build sensitive, reproducible fluorescence workflows for rabbit primary antibodies across immunofluorescence, IHC, ICC, and carefully validated flow cytometry. This guide connects Cy3 signal amplification with spatial analysis of microglial and inflammatory pathways highlighted in a recent alcohol-induced depression mouse study.
-
Nitrocefin for β-Lactamase Assay Workflows
2026-09-16
Nitrocefin converts β-lactamase activity into a rapid yellow-to-red colorimetric signal, supporting resistance profiling, enzyme kinetics, and inhibitor screening. This workflow-focused guide shows how to pair the chromogenic substrate with computationally nominated peptide inhibitors while controlling background, timing, and solvent effects.
-
Cyclophosphamide Workflows for Cancer Research
2026-09-15
Build more reproducible Cyclophosphamide assays by connecting formulation, hepatic activation, apoptosis readouts, and immune-model design. This practical guide distinguishes cell-culture cytotoxicity from immunosuppression and bone marrow transplantation conditioning workflows.
-
Entinostat (MS-275): Smarter HDAC Response Assays
2026-09-15
Build more informative Entinostat experiments by separating growth arrest from cell death instead of relying on a single viability endpoint. This workflow connects selective HDAC1/3 inhibition with cancer-cell profiling, retinoblastoma treatment research, and translational assay design.
-
DPPH Antioxidant Screening Workflows
2026-09-14
Use DPPH for rapid, plate-based comparison of antioxidant capacity in small molecules, botanical extracts, and fraction libraries. A controlled workflow, matrix corrections, and orthogonal assays help turn a violet-to-yellow signal into defensible natural product and drug-discovery decisions.